Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Routine Shallow-coverage Whole Genome Sequencing Testing of Liquid-based Cervical Smears for the Early Diagnosis of Ovarian Cancer

NCT07821879 is registered in ClinicalTrials.gov with Institut Claudius Regaud as lead sponsor.

NCT NCT07821879
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07821879 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Routine Shallow-coverage Whole Genome Sequencing Testing of Liquid-based Cervical Smears for the Early Diagnosis of Ovarian Cancer
Lead sponsor
Institut Claudius Regaud
Phase
Observational
Overall status
Recruiting
Start date
January 5, 2025
Completion date
January 4, 2027
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cervical cancer screening, genomic instability, high grade serous ovarian cancer, whole genome sequencing